Long-Term Assets: The sum of all assets classified as non-current.
BioXcel Therapeutics, Inc. (BTAI) had Long-Term Assets of $0.79M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.17M |
|
$-7.25M |
|
$0.01M |
|
$0.15M |
|
$10.27M |
|
$-10.10M |
|
$2.85M |
|
$-7.25M |
|
$-7.25M |
|
$-7.25M |
|
$-7.25M |
|
$-7.25M |
|
$-7.25M |
|
$-10.10M |
|
$-10.02M |
|
4.83M |
|
4.83M |
|
$-1.50 |
|
$-1.50 |
|
| Balance Sheet Financials | |
$37.78M |
|
$0.40M |
|
|
Long-Term Assets |
$0.79M |
$38.57M |
|
$25.55M |
|
$99.92M |
|
$103.19M |
|
$128.74M |
|
$-90.17M |
|
$-90.17M |
|
$-90.17M |
|
5.47M |
|
| Cash Flow Statement Financials | |
$-12.04M |
|
-- |
|
$13.20M |
|
$29.85M |
|
$31.01M |
|
$1.16M |
|
$0.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.48 |
|
-- |
|
-- |
|
10.25 |
|
-1.17 |
|
91.67% |
|
-6011.31% |
|
-6011.31% |
|
-- |
|
-4317.86% |
|
-4317.86% |
|
$-12.04M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.02 |
|
-- |
|
-- |
|
8.04% |
|
8.04% |
|
-18.81% |
|
-74.43% |
|
$-16.49 |
|
$-2.49 |
|
$-2.49 |
|